FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.

by Bajetta, E., Di Bartolomeo, M., Carnaghi, C., Buzzoni, R., Mariani, L., Gebbia, V., Comella, G., Pinotti, G., Ianniello, G., Schieppati, G., Bochicchio, A. M., Maiorino, L.
Published 1998

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.

by Bajetta, E., Zilembo, N., Buzzoni, R., Noberasco, C., Di Leo, A., Bartoli, C., Merson, M., Sacchini, V., Moglia, D., Celio, L.
Published 1994

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.

by Buzzoni, R., Biganzoli, L., Bajetta, E., Celio, L., Fornasiero, A., Mariani, L., Zilembo, N., Di Bartolomeo, M., Di Leo, A., Arcangeli, G.
Published 1995

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

by Zilembo, N., Noberasco, C., Bajetta, E., Martinetti, A., Mariani, L., Orefice, S., Buzzoni, R., Di Bartolomeo, M., Di Leo, A., Laffranchi, A.
Published 1995